An essential source of information and analysis on the global Alzheimer’s disease market. The report identifies the key trends shaping and driving the dynamism in the global Alzheimer’s disease market.

The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global Alzheimer’s disease sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by our team of industry experts.


Scope

The scope of the report includes:

- Annualized global Alzheimer’s disease market revenues data from 2000 to 2008, forecast forward for 7 years to 2015.

- Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.

- Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. Key classes of mechanism of action include immunotherapy, NMDA agonists, acetylcholine inhibitors, gamma secretase modulators, serotonin receptor antagonists, muscarinic receptor agonists, alpha secretase enhancers, beta secretase inhibitors, tau inhibitors and non-steroidal anti-inflammatory classes of drugs.

- Analysis of the current and future market competition in the global Alzheimer’s disease market. Each trend is independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these trends.

- Insightful review of the future market players, key industry drivers, restraints and challenges which are likely to impact the Alzheimer’s disease therapeutics market in the long run. Key future market players covered are Wyeth, Elan, Astrazeneca, Medivation and Baxter Healthcare.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with Alzheimer’s disease.


Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:

- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global Alzheimer’s disease market.

- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global Alzheimer’s disease market in future.

- L2Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

- What’s the next big thing in the global Alzheimer’s disease market landscape? – Identify, understand and capitalize.

Table of Contents



61 pages

Publication Date : December 2009